US Patent 11357820 GIP/GLP1 agonist compositions
Patent 11357820 was granted and assigned to Eli Lilly and Company on June, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11357820 GIP/GLP1 agonist compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.